Skip to main content
Download PDF

Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer

Journal of Translational Medicine volume 22, Article number: 420 (2024) Cite this article

The Original Article was published on 29 February 2024

Correction to: Journal of Translational Medicine (2024) 22:213

https://doi.org/10.1186/s12967-024-05027-8

Following publication of the original article [1], we have been notified that the Funding note was published incorrectly.

It is now:

Dr. Maugeri-Saccà is supported by the Italian Association for Cancer Research (AIRC) under MFAG 2019 (project identification: 22940) and the Italian Ministry of Health (MoH) (project identification: GR-2016?02362025).

It should be:

This work was financially supported through funding from the institutional “Ricerca Corrente” granted by the Italian Ministry of Health.

References

  1. Schiavoni et al. (2024) Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer (2024). 22:213 https://doi.org/10.1186/s12967-024-05027-8.

Download references

Author information

Authors and Affiliations

  1. Clinical Trial Center, Biostatistics and Bioinformatics Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy

    Giulia Schiavoni, Beatrice Messina & Marcello Maugeri-Saccà

  2. SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy

    Stefano Scalera

  3. Pathology Unit, Mediterranean Institute of Oncology, Viagrande, Italy

    Lorenzo Memeo & Cristina Colarossi

  4. Medical Oncology Unit, Mediterranean Institute of Oncology, Viagrande, Italy

    Marzia Mare

  5. Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, Messina, Italy

    Marzia Mare

  6. Translational Oncology Research Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy

    Giovanni Blandino

  7. Scientific Directorate, IRCCS Regina Elena National Cancer Institute, Rome, Italy

    Gennaro Ciliberto

  8. Cellular Network and Molecular Therapeutic Target Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy

    Giulia Bon

  9. Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy

    Marcello Maugeri-Saccà

Authors
  1. Giulia Schiavoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beatrice Messina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefano Scalera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lorenzo Memeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cristina Colarossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marzia Mare
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giovanni Blandino
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gennaro Ciliberto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Giulia Bon
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Marcello Maugeri-Saccà
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giulia Bon.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s12967-024-05027-8.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schiavoni, G., Messina, B., Scalera, S. et al. Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer. J Transl Med 22, 420 (2024). https://doi.org/10.1186/s12967-024-05161-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12967-024-05161-3

Journal of Translational Medicine

ISSN: 1479-5876

Contact us